Latest News- Antibiotics Market: Broad-spectrum antibiotics is expected to lead the Product segment during 2025-2029

The Antibiotics Market is being driven by Rising prevalence of infectious diseases

The Antibiotics Market is expected to grow at a CAGR of 5.9% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 18.22 billion. The antibiotics market is experiencing a significant trend of mergers and acquisitions among major players, driven by the imperative to expand market share, broaden product offerings, and optimize operational efficiencies. For instance, in May 2023, Virbac's acquisition of GS Partners marked a strategic move to fortify its presence in Central Europe. This deal expanded Virbac's geographical reach and enhanced its capabilities in the pet and ruminant segments, enabling it to better address the health needs of animals in the Czech Republic and Slovakia, thereby bolstering its market position. This consolidation strategy is a common theme in the antibiotics industry as companies seek to leverage synergies and strengthen their competitive stance. 

Get more information on Antibiotics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Broad-spectrum antibiotics
  • Narrow-spectrum antibiotics
• Route Of Administration
  • Intravenous
  • Oral
  • Others
• Geography
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • France
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rising prevalence of infectious diseases
• Government investment regarding antibiotics
• Growing awareness of various diseases and their treatment

However, the market also witnesses some limitations, which are as follows:

• High research and development costs and long development cycles
• Stringent regulation associated with antibiotics
• Development of antibiotic-resistant strains

Benefits of Buying Global Antibiotics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Antibiotics Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Antibiotics Market encompasses various aspects of antibiotic research and development, including bacterial identification, antibiotic pharmacokinetics and pharmacodynamics, in vitro susceptibility testing, and in vivo efficacy studies. Toxicity assessments, clinical trials, and adverse drug reactions are also crucial components. Drug interactions, patient compliance, infection control, and healthcare-associated infections are significant areas of focus. Microbial pathogenesis, immune response, wound healing, and tissue regeneration are integral to understanding antibiotic action. Drug development, delivery systems, novel antibiotic targets, antimicrobial peptides, and prophylactic antibiotics are key areas of innovation.

Market Research Overview

The antibiotics market, a significant segment of the global pharmaceuticals industry, encompasses entities involved in the research and development (R&D) or production of antibacterial drugs for human and veterinary use. According to Technavio's market analysis, the healthcare sector's total revenue is determined by the combined earnings of manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Factors fueling the expansion of the pharmaceuticals market include the increasing elderly population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to be over 60 years old. This demographic shift will increase the demand for antibiotics to combat age-related bacterial infections, such as urinary tract infections and pneumonia. Additionally, the emergence of antibiotic resistance genes necessitates the development of new antibiotics to counteract these genes' effects on protein synthesis inhibition and minimum inhibitory concentration.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/